Abiopharma

🔍 Oaktree Capital Group Holdings GP, LLC (Executive)

Company: SunOpta Inc. (STKL)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Sold 20,651,812 shares of Common Shares at $6.5 per share (Direct)
  Date: 2026-05-01 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 12,178,666 shares of Series B-1 Preferred Stock at $2.5 per share (Derivative)
  Date: 2026-05-01 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F4, F4, F4, F4, F2
• Sold 0 shares of Special Shares, Series 2 (Derivative)
  Date: 2026-05-01 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F6, F6, F6, F6, F6, F2
• Sold 871,170 shares of Cash-Settled Total Return Swap at $12.08 per share (Derivative)
  Date: 2026-05-01 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F7, F7, F7, F7, F2
• Sold 4,404,034 shares of Cash-Settled Total Return Swap at $12.08 per share (Derivative)
  Date: 2026-05-01 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F7, F7, F7, F7, F2

Footnotes:

• F1: The reported securities were disposed of in connection with the consummation of the plan of arrangement (the "Plan of Arrangement") of SunOpta Inc. (the "Issuer") and 2786694 Alberta Ltd. (the "Purchaser").
• F2: Oaktree Capital Holdings, LLC ("OCG") and Oaktree Capital Group Holdings GP, LLC ("OCGH GP"), in its capacity as the duly appointed manager of OCG, indirectly control each of the direct holders of the reported securities and, accordingly, may each be deemed to beneficially own the reported securities, but each of the reporting persons disclaims beneficial ownership except to the extent of its pecuniary interest therein.
• F3: Represents 17,241,579 Common Shares held directly by Oaktree Organics, L.P. ("Oaktree Organics") and 3,410,233 Common Shares held directly by Oaktree Huntington Investment Fund II, L.P. ("OHIF").
• F4: Pursuant to the Plan of Arrangement, each issued and outstanding share of the Series B-1 Preferred Stock in the capital of SunOpta Foods, Inc. ("Series B-1 Preferred Stock"), a wholly-owned subsidiary of the Issuer was transferred to the Issuer in exchange for an aggregate of 12,178,666.40 Exchange Shares, calculated by multiplying the number of shares of Series B-1 Preferred Stock by 405.9555467 (being the exchange rate of the Series B-1 Preferred Stock contemplated by their terms), and the resulting Exchange Shares were transferred to Purchaser in exchange for a cash payment of $6.50 per share.
• F5: The reported securities were directly held as follows: (i) 12,538.52 shares of Series B-1 Preferred Stock held by Oaktree Organics; (ii) 2,461.48 shares of Series B-1 Preferred Stock held by OHIF; and (iii) 15,000 shares of Series B-1 Preferred Stock held by OCG.
• F6: Represents Special Shares, Series 2, directly held by Oaktree Organics, OHIF, and OCG, which pursuant to the Plan of Arrangement, were disposed of for no consideration.
• F7: OHIF and Oaktree Special Situations Fund, L.P. (together, the "Trading Funds") were parties to certain cash-settled total return swaps with respect to the reported number of common shares of the Issuer (the "Cash-Settled Swaps"). Pursuant to their terms, upon termination of the Cash-Settled Swaps, the Trading Funds were obligated to pay to the counterparty any negative price performance of the terminated quantity of the Issuer's common shares, and the counterparty was obligated to pay the Trading Funds any positive price performance of the specified quantity of the Issuer's common shares. In connection with consummation of the Plan of Arrangement, the Cash-Settled Swaps were terminated pursuant to their terms.
• F8: OCG is indirectly the general partner or manager of each of the Trading Funds.